Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp > Vertex and Witkowski Partnership
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Comment by Mercuryfilling1on Feb 22, 2022 12:30pm
232 Views
Post# 34450618

RE:RE:RE:RE:RE:RE:RE:Vertex and Witkowski Partnership

RE:RE:RE:RE:RE:RE:RE:Vertex and Witkowski Partnership
Metalsguy1 wrote:
sailboat..you are wasting your breath on Merc a derp. He is a company shill. Management is either a consummate liar or grossly incompetent. Every investor I know here has been told a slightly different story and not one of them has turned out to be true. At this point I am holding my position for the singular purpose of voting against the BOD and management. We sit around waiting for something of substance that never materializes while DSUs rain down on management.


There goes Metals, stamping his little feet again.

No, I'm not a company shill. I've been invested here since SVA was Pheremone Sciences and they were cranking out fertiity watches.

https://www.wsj.com/articles/SB112898328788264846

Maybe Metals you should get one...you could identify your most fecund vs most hysterical moments.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities